Delivery Order SPE2DB22D3016-SPE2DB24FARF9
Award Date 3/29/24
Potential Completion Date 4/1/24
Potential Value $6.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,046.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CAPLYTA 42 MG CAPSULE 30S. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of CAPLYTA 21 mg capsules (30-count units) under a firm fixed-price contract valued at $4,207.95, with an ultimate completion date of January 12, 2026. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026 that serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,018.07 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of CAPLYTA 21 MG CAPSULE 30S, with a completion date of March 7, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds two significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,746.70 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,086.74 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 MG capsules (30-count units) under a firm fixed-price contract. The delivery order, issued on February 2, 2026, with an ultimate completion date of February 3, 2026, represents a non-set-aside, competitively awarded transaction. Performance of this order will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- This federal contract award is a delivery order valued at $25,563.63 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through March 19, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,839.70 firm fixed-price delivery order is for the supply of CAPLYTA 42 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,124.86, is for the delivery of CAPLYTA 42 MG CAPSULE 30S medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,134.39, is for the delivery of CAPLYTA 42 MG CAPSULE 30S, a medication, to support DLA's medical supply requirements. The contract has an ultimate completion date of June 13, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 14, 2026, valued at $29,851.47 for the supply of CAPLYTA 21 mg capsules (30-count units) to support federal medical procurement needs. This non-set-aside contract was competitively awarded through firm fixed-price pricing and is set for completion by January 15, 2026. The award was made by the Defense Logistics Agency (DLA), the federal entity responsible for supply chain management across the...